180-Kda Spike Protein
10-180 kDa Protein Marker |
|||
| 20-abx098877 | Abbexa |
|
|
Human IgG antibody Laboratories manufactures the 180-kda spike protein reagents distributed by Genprice. The 180-Kda Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other 180-Kda products are available in stock. Specificity: 180-Kda Category: Spike Group: Protein
L-NAME hydrochloride |
||
| Glentham Life Sciences | 25 g | EUR 246 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 5 g | EUR 103.2 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 1 | EUR 15.9 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 25 | EUR 174 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 5 | EUR 55.4 |
Recombinant SARS-CoV Spike protein [GST] (37 kDa) |
||
| Creative Biolabs | inquire | Ask for price |
|
Description: SARS-CoV C-terminal of the Spike protein (37 kDa), recombinant protein from E. coli, 1 mg/mL. |
||
Recombinant SARS-CoV Spike protein [GST] (38 kDa) |
||
| Creative Biolabs | inquire | Ask for price |
|
Description: SARS-CoV middle region of the Spike protein (38 kDa), recombinant protein from E. coli, 1 mg/mL. |
||
COVID-19 Spike Protein a.a. 800 to 1000 |
|||
| 00222-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: COVID-19 Spike Protein a.a. 800 to 1000 |
|||
MERS-CoV Spike protein (aa 1-1297) [His] |
|||
| DAG-H10300 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike Protein (aa 367-606) [His] |
|||
| DAGB201 | Creative Diagnostics | 20 µg | EUR 868.8 |
MERS Spike S1 Recombinant protein |
|||
| 39-102 | ProSci | 0.1 mg | EUR 556.8 |
|
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis. |
|||
Recombinant SARS Spike Protein (aa 1-1190) [His] |
|||
| VAng-Lsx0063-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: SARS Spike protein (aa 1-1190) [His], recombinant protein from HEK 293 cells. |
|||
COVID-19 Spike S1 protein a.a. 1 to 800 |
|||
| 00226-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: COVID-19 Spike S1 protein a.a. 1 to 800 |
|||
MERS-CoV Spike protein S2 (aa 726-1296) [His] |
|||
| DAG-H10296 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike protein S1 (aa 1-725) [His] |
|||
| DAG-H10298 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike protein S1 (aa 1-725) [His] |
|||
| DAG-H10301 | Creative Diagnostics | 20µg | EUR 868.8 |
SARS Spike RBD Recombinant Protein |
|||
| 10-211 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
|||
Mouse Monoclonal Anti-SARS Spike Protein IgG |
|||
| AB-15710 | Alpha Diagnostics | 20 ug | EUR 489.6 |
2019-nCoV Spike Protein (S1 Subunit, His Tag) |
|||
| BSV-COV-PR-02 | BioServUK | 100 ug | Ask for price |
|
Description: 2019-nCoV Spike Protein (S1 Subunit, His Tag) |
|||
Recombinant Coronavirus Spike Protein (SARS-CoV S2) |
|||
| P1519-10 | Biovision | 10µg | EUR 187.2 |
Recombinant Coronavirus Spike Protein (SARS-CoV S2) |
|||
| P1519-50 | Biovision | 50µg | EUR 661.2 |
Recombinant MERS-CoV Spike Protein (aa 1-1297) [His] |
|||
| VAng-Wyb7329-100g | Creative Biolabs | 100 µg | EUR 3249.6 |
|
Description: Middle East respiratory syndrome coronavirus (NCoV / Novel coronavirus) Spike protein, recombinant protein. |
|||
Recombinant MERS-CoV Spike Protein (aa 1-1297) [His] |
|||
| VAng-Wyb7329-20g | Creative Biolabs | 20 µg | EUR 1198.8 |
|
Description: Middle East respiratory syndrome coronavirus (NCoV / Novel coronavirus) Spike protein, recombinant protein. |
|||
Recombinant MERS-CoV Spike Protein (aa 1-1297) [His] |
|||
| VAng-Wyb7329-50g | Creative Biolabs | 50 µg | EUR 2096.4 |
|
Description: Middle East respiratory syndrome coronavirus (NCoV / Novel coronavirus) Spike protein, recombinant protein. |
|||